SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

HeartMate 3 LVAD

With Full Maglev Flow Technology

ARIES-HM3

ARIES-HM3 Outcomes

ARIES-HM3 trial is the first and only international randomized controlled trial to study the effects of avoidance of aspirin on LVAD patients. Trial outcomes demonstrated that avoidance of aspirin in newly implanted adult HeartMate 3™ LVAD patients is safe and significantly reduces the risk of bleeding events.*1

View Publication

HeartMate 3 LVAD is a proven long-term, life-extending therapy.2 By avoiding aspirin, outstanding outcomes are made even better.*1

Nearly 40% reduction in GI bleeding events

39%

Reduction in hospitalization days due to bleeding events**

Reduction in hospital stays

Reduction of cost of care for bleeding events**

reduction in cost of care
For more information

For more information on management of hemocompatibility related adverse events and aspirin usage for LVAD patients, read the ISHLT Consensus Statement

Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets

 

*Newly implanted HeartMate 3 LVAD patients. Studied only in patients 18 and over. Decisions regarding the pharmacological management of HeartMate 3 LVAD patients should be individualized by clinicians after fully considering potential risks and benefits

**Based on US patients only.

 

References:

  1. Mehra MR, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023 Dec 12;330(22):2171-2181. doi: 10.1001/jama.2023.23204. PMID: 37950897; PMCID: PMC10640705
  2. Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. September 8, 2022. doi:10.1001/jama.2022.16197

MAT-2409768 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0